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Dilute bleach (sodium hypochlorite, NaOCl) baths are commonly recommended 
in clinical practice guidelines for pediatric eczema, also known as atopic dermatitis (AD) 
management.1 Although the original randomized control trials (RCT) of bleach baths 
were promising, subsequent RCTs have shown conflicting results.2 Currently, no studies 
investigate the role of improving environmental hygiene in reducing the severity of 
atopic dermatitis. This paper seeks to explore the efficacy of bleach baths in the context 
of improvement of the bathroom hygiene environment on severity of pediatric atopic 
dermatitis. 
At the start of the study, two-thirds of the participating patients were randomized 
to have a culture taken from their bathtub, followed by cleaning of all of their bathrooms 
(intervention arm); the remaining  one-third of the sample only had a culture taken from 
their bathtub, with no cleaning (control arm). After investigators cleaned  the bathrooms 
in the intervention arm, this group was randomized again, with  half receiving 
instructions on performing twice weekly bleach baths and the other half not receiving 
these instructions. Study outcomes included POEM (patient-oriented eczema 
measurement) scoring at time of home visit, 1 week after visit, and 4 weeks after visit, 
as well as bathtub culture results and rates of infection. This study design was modestly 




resulted in our having a final sample of 58 patients, rather than the 60 for which we had 
hoped.  
This study revealed no significant difference in POEM score between the patients 
who received a bathroom cleaning and those who were in the bleach bath group. The 
control group showed a statistically significantly higher POEM score, indicating higher 
morbidity caused by their atopic dermatitis than was experienced in the bleach bath or 
cleaning group.  
 
This study suggests that the efficacy of bleach baths in AD may be the result of 
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 Atopic dermatitis (AD) is the most common skin disease in childhood and is the 
leading cause of pediatric dermatology visits in developed nations (Silverberg et al., 
2017).  AD is a chronic, inflammatory skin disease characterized by pruritis, 
inflammatory erythematous skin lesions, and skin-barrier defect (Nguyen et al., 2019).  
Current AD treatments include use of emollients, steroids, calcineurin inhibitors, and 
systemic immunomodulators (Silverberg et al.,2017). Dilute bleach (sodium 
hypochlorite, NaOCl) baths are commonly recommended in clinical practice guidelines 
for pediatric eczema, also known as atopic dermatitis (AD) management (Eichenfield, 
2004, Weitz et al., 2006). Bleach baths are proposed to suppress epidermal 
Staphylococcus Aureus load, which subsequently improves atopic dermatitis severity 
(Guzik et al., 2015). Although the original randomized control trials (RCT) of bleach 
baths were promising, subsequent RCTs have shown conflicting results (Chopra et al., 
2017). Additional evidence from a Cochrane review indicates that reducing the load of 
Staphylococcus Aureus in patients with atopic dermatitis does not provide clinical 
benefit in the absence of active infection (Bath-Hextall, 2010).  
Currently, no studies investigate the role of improving environmental hygiene in 
reducing the severity of atopic dermatitis. This question is controversial, as the current 
“hygiene hypothesis” postulates that exposure to “dirtier environments” in which children 
are exposed to more bacterial and viral pathogens is protective against atopic dermatitis 
(Flohr & Yeo, 2011). This paper seeks to explore the efficacy of bleach baths in the 
context of improvement of the bathroom hygiene environment on severity of pediatric 





BACKGROUND AND SIGNIFICANCE 
 
Environmental Hygiene and Atopic Dermatitis  
The “atopic triad” of disease includes asthma, atopic dermatitis, and allergies; 
they are commonly inherited together and are a result of hypersensitivity to certain 
stimuli (Kapoor et al., 2008). The relationship between environmental interventions and 
disease severity is much better understood in conditions like asthma than for atopic 
dermatitis. In asthma, home-based multi-trigger, multicomponent interventions with an 
environmental focus for children and adolescents with asthma show strong evidence for 
improving asthma symptoms, reducing the number of days of school missed due to 
asthma, and improve overall quality of life (Crocker et al., 2011). In contrast, studies 
looking at environmental hygiene interventions for atopic dermatitis are formulated to 
search for hygiene improvements as the cause of atopic dermatitis, rather than factor of 
improvement. One atopic dermatitis study evaluated the effect of more frequent hand 
washing and the use of antiseptics in daycare centers on the development of allergies 
later in life and found that more hygienic daycares do not increase the risk for allergies 
(Dunder et al., 2007).  Another study found that children who live in families who wash 
themselves more frequently have a higher risk for atopic dermatitis, however, the 
authors only assessed skin washing (not environmental hygiene), and their finding was 
likely of irritation of the skin barrier caused by increased soap use, rather than a 
reduction in pathogen exposure (Sherriff & Golding, 2002; Flohr & Yeo, 2011). 
Additionally, these studies did not assess the relationship between increasing 




disease. Finally, the gut microbiome of children with atopic dermatitis is more often 
colonized with Staphylococcus aureus and coliform microbes, with these changes often 
preceding clinical manifestations of atopic dermatitis (Bjorksten et al., 1999; Bjorksten et 
al., 2001; Wantanabe et al., 2003). Currently, the relationship between environmental 
hygiene and atopic dermatitis severity has not been explored in relation to the gut 
microbiome. If atopic dermatitis behaves similarly to asthma, it is plausible that an 
intervention that reduces mold and bacteria in the bathroom environment could improve 
atopic dermatitis severity.  
 
Environmental Hygiene Methods 
The Centers for Disease Control and Prevention (CDC) publishes guidelines on 
safely cleaning homes by homecare workers (CDC, 2015 and CDC, 2018). Tubs, tiles, 
showers, and toilets are recommended to be cleansed with baking soda mixed with 
warm water. Floors can be cleansed with white vinegar diluted in water. Hard surfaces, 
including floors, sinks, certain toys, and countertops with evidence of mold growth can 
be cleansed with dilute bleach. The cleaning intervention used in this project included 
only these cleansing agents (water, dish soap, white vinegar, baking soda, and bleach 
when indicated) as they are relatively inexpensive and widely available agents that 
could be generalized to diverse populations if the intervention is proven to be clinically 
effective.  
The role of the bathroom environment in atopic dermatitis and allergy is 
unknown. This study evaluates whether part of the efficacy of bleach baths in atopic 




presumably reducing the amounts of bacteria and mold located in the bathtub. If shown 
to be clinically effective at reducing both the number of infections and the disease 
severity of atopic dermatitis, improved bathroom hygiene may change the current 
clinical practice guidelines of recommendations for dilute bleach baths in children with 
eczema. Additionally, the use of inexpensive and widely available agents to clean 
bathrooms (water, dish soap, white vinegar, bleach, and baking soda) would be 





I recruited willing patients and their families by in-person invitations from 
Pediatric Dermatology clinics at The University of North Carolina at Chapel Hill from 
August 2019- February 2020. I intended to recruit 60 families to participate and powered 
the study for that N of cases.  At the start of the study, two-thirds of the patients (40 
patients) were randomized to have a culture taken from their bathtub, with subsequent 
cleaning of all of their bathrooms by the lead investigator (intervention arm), with one-
third (20 patients) only having a culture taken from their bathtub with no cleaning 
(control arm). After I, the lead investigator, cleansed the bathrooms most often used by 
the children with AD in the intervention arm, I randomized this group again, such that 
half of this group (20 patients) receives instructions on performing twice weekly bleach 
baths and the other half (20 patients) does not (see Appendix). The COVID-19 global 
pandemic suspended all field research at UNC in early Spring 2020.  Fortunately, I had 




result, the study to date includes 20 patients in the cleaned bathroom plus bleach bath 
arm, 19 patients in the cleaned bathroom arm, and 19 in the control arm.  
This project included four quantitative assessment phases. Upon entry into the 
study, I collected basic demographic information (race/ethnicity, age, insurance status), 
a history of skin infections and allergic diseases, an atopic dermatitis severity score 
(POEM or Patient Oriented Eczema Measure), an atopic dermatitis area and severity 
score (EASI score, or eczema assessment and severity index), and recorded level of 
AD therapy (weak-moderate topical steroids, strong topical steroids, or systemic 
immunomodulators). I obtained cultures from the bathtub used by every child with AD 
recruited into the study. I obtained a POEM score on the date of scheduled swab or 
cleaning, followed by getting a one-week follow up POEM score over the phone, as well 
as a 4-week POEM score. Additionally, I kept detailed field notes of my own perceptions 
and experiences using a structured note-taking tool for every home visit during the 
cleaning process (Appendix Item4). Domains assessed in the field notes include 
environment, work difficulty, and assessment of usefulness to the family. Environmental 
notes included the general appearance of the exterior of the home and neighborhood, 
cleanliness and order within the home and bathroom, the hospitality and dynamics of 
family interactions. Work difficulty notes included description of activities performed and 
any physical, mental, and emotional toil related to the labor with suggestions for 
improving the work experience. Assessment of usefulness to the family included patient 
and family perception of intervention, willingness to complete dilute bleach baths, and 




home visit field notes were coded by a single investigator, me; I evaluated the results for 
recurring themes.  
I randomized participating families into one of three interventions using the 
RANDBETWEEN function in Excel. While it was not possible to blind participants to 
which intervention they were randomized to, the POEM scores were obtained by a 
blinded investigator. I contacted participants via phone with the results of their bacteria 
culture at 4 weeks following the home visit, and I gave all participants instructions on 
cleaning the bathroom at the 4-week mark, regardless of intervention arm.  
Study inclusion criteria were children with atopic dermatitis between 6 months 
and 18 years of age who visited UNC Pediatric Dermatology during the study enrollment 
period who were on a class 1 topical steroid or systemic immunosuppressive agent to 
control his or her eczema at the time of recruitment. Additionally, I required that 
potential participants had a history or current clinical evaluation by a Board-Certified 
Pediatric Dermatologist showing atopic dermatitis affecting at least 10% of total body 
surface area to participate in this study. Exclusion criteria included the patient or family 
member with a sensitivity to bleach, a child that has used bleach baths within the last 
two months, or children who took showers instead of baths.  
I performed statistical analysis in Microsoft Excel. Wilcoxon ranked sum test was 
used to test for normal distribution among each group, with p value <0.05 being 
considered a statistically significant difference. Fisher’s combined probability test and 
chi squared test were used to detect differences in POEM scores, EASI scores, and 








Study Sample Characteristics 
  
As I noted above, this study was originally intended to be statistically powered for 60 
patients, however the restrictions imposed in response to the COVID-19 global 
pandemic interrupted data collection near the end of the recruitment period. As a result, 
there were 20 patients in the bleach bath arm, 19 patients in the bathroom cleaning 
arm, and 19 in the control arm, for a total of 58 patients. This study sample was mainly 
represented by children who identified as black, white, or Asian (see Table 1). The 
average age of study participants was 7.35 years, and locations of homes were 
distributed throughout the state of North Carolina, primarily concentrated in the central 
area of the state (see Figure 3). Self-reported race of participants was black (48.3%), 
white (31.7%), Asian (5%), multiracial (10%), and other (3.3%) (see Table 1). Study 
participants also self-reported insurance coverage of Medicaid (55%), Blue Cross Blue 
Shield (16.7%), Tricare, or health insurance for the families of active duty military 
personnel (10%), and others (18.3%) (see Table 1). I obtained background medical 
history of atopic disease, skin infections, current antibiotic use, and type of treatment for 
AD upon families’ enrollment in the study. Atopic disease history of participants included 
previous diagnosis of asthma (40%), history of hay fever (71.7%), and history of food 
allergies (40%) (see Table 2). Infection history of participants included prior history of 
skin infections requiring treatment with antibiotics (51.7%), current topical antibiotic use 
(6.7%), and current systemic antibiotic use (8.3%) (see Table 2). Participant AD 




immunomodulator (31.7%) and other (3.3%) (see Table 2). Baseline assessment of AD 
severity was a combination of treatment regimen, EASI score, and POEM score (see 
Appendix 2). Average EASI score at time of study enrollment was 11.84 (see Table 3) 
and average POEM was 13.88 (see Table 4). Six participants did not complete the full 
study, because they were moving homes, or parents could not be home at the time of 
home visit, or they did not answer during attempts to contact for follow up surveys. 
Analysis of Home Visit Themes Emerging from Field Notes 
 I concluded each home visit with an interview and a write up of my own 
experiences with cleaning, patient and family education, and relevant notes on living 
environment (see Appendix 2, Item 4). These notes show that participants with higher 
baseline EASI and POEM scores were more likely to live in rented homes, have 
noticeable odor of smoke within the home, live in crowded homes with shared 
bathrooms, use fragrances or air fresheners within the home, have carpet throughout 
the home, and excessive mold within the bathtub (see Figure 1). Participants with lower 
baseline EASI and POEM scores were more likely to live in homes with tile or wood 
floors, to own their homes, to have minimal mold in the bathtub, use home cleaning 
services, and were more likely not to have noticeable odors of smoke, air fresheners, or 






Bathtub Culture Results 
 I swabbed bathtubs at the start of each home visit and sent them to UNC 
Microbiology Labs to determine flora present in the tub prior to cleaning. The most 
commonly isolated bacterium was Staphylococcus aureus (12), followed by KEE 
organisms (grouped Klebsiella, Enterobacter, Escherichia coli) (7), and Methicillin 
Resistant Staphylococcus aureus (2) (see Figure 1 and Table 5). The majority of 
bathtubs were found not to have S. aureus, KEE, or MRSA (31). In a small number of 
cases, I could not obtain samples from bathtubs because of dropouts or missing lab 
samples (6). There was no statistically significant difference in isolated flora between 
the bleach bath group, cleaning group, and control group (Fisher p = 0.9874). Families 
who were not randomized into the cleaning group who were found to have potentially 
pathogenic bacteria were contacted and given instructions on disinfecting their bathtubs 
(see Appendix 2 Item 3).  
 
Post Intervention Results 
 I contacted participants at one week and 4 weeks following initiation of their 
respective interventions. No statistically significant difference was detected between 
baseline and post-intervention POEM scores in the bleach bath group and the bathroom 
cleaning group (Wilcoxon p= 0.1458) (see Table 6). The average change in 4-week 
POEM score for the bleach bath group was 1.94. The average change in 4-week POEM 
score for the bathroom cleaning group was 4.  The average change in the 4-week 




self-report on skin infections experienced within the last 4 weeks. The bleach bath 
group and cleaning group combined had a 2.5% infection rate while the control group 
had a 5% (see Table 7). The bleach bath group and cleaning group also had a 12.5% 
use of systemic antibiotics within the 4-weeks following the intervention, while the 
control group had 15% (see table 7).  
Additionally, 10% of participants in the bleach bath and cleaning intervention 
groups report use of systemic steroids, while the control group reported a rate of 15% 
use (see Table 7). The bleach bath group and cleaning group also reported that 5.1% of 
participants required a visit to their medical provider for an AD flair within the four weeks 
following the intervention, while the control group reported twice as many, or 10%, that 
they needed to see their providers (see Table 7). Six participants did not complete the 
full study, because they were moving homes, or parents could not be home at the time 
of home visit, or they did not answer during attempts to contact for follow up surveys. 
Four of these patients were Medicaid patients, with the most common reason of these 





This convenience sample of 58 children from 36 counties demonstrates strong 
associations between the bathroom environment and severity of pediatric AD. This 
study suggests that the efficacy in bleach baths for AD treatment may not be exclusively 
beneficial via decolonization of skin, but also by contributing to improvement in hygiene 
of the bathroom environment.  These findings are consistent with prior literature about 




increasing disease severity (Dunder et al., 2007). However, this study may call for 
reconsideration of the previous hygiene hypothesis, which postulated that “dirtier 
environments” in which children are exposed to more bacterial and viral pathogens, are 
protective against atopic dermatitis (Flohr & Yeo, 2011). Both the bleach bath group and 
bathroom cleaning group had improved POEM scores, while the control group did not.  
The two intervention groups also had lower infection rates, medical visits for AD flairs, 
steroid use, and antibiotic use (see Table 7). The failure of differences  between the 
bleach bath group and the bathroom cleaning group for these outcome measures may 
be a result of the small subsample sizes, indicating a strong need for future research, in 
larger numbers of participating families, to differentiate the effects of having bleach 
water on the skin and having a disinfected bathtub.   
 As is the case in so many other disease states, the effects of social determinants 
of health are moving to the forefront in consideration of disease severity for AD (Tackett 
et al.,2019). Social determinants of health have been defined as “the conditions in which 
people are born, grow, live, work, and age, which are in turn shaped by the distribution 
of power, money, and resources within and between countries” (Baker et al., 2018). 
Variables like socioeconomic status, environment, and poor disease outcomes have 
been linked by the theory of fundamental causes (Link et al., 1995). This theory 
provides a framework for understanding why health inequities continue to exist despite 
medical advances and efforts to eliminate them at the individual and health systems 
level. The theory of fundamental causes prioritizes the availability of resources to 
persons with higher socioeconomic status, such as knowledge, power, money, and 




can be used despite any risk or protective factors to improve health (Phelan et al., 
2010). This theory may enrich our understanding of the results from the  findings and 
themes I collected during home visits, including meeting and witnessing participants 
with lower socioeconomic status, less hygienic bathroom environments, and living in 
potentially lower-resource neighborhoods having higher measures of AD severity, 
including higher EASI and POEM scores (see Figure 3). These findings comport with 
studies and national data for numerous other disease states, underlining the importance 
of affordable housing, clean environments, jobs that pay a living wage, and access to 
clinical care and healthy foods (Acevedo-Garcia et al., 2003). Despite this data, few 
countries have systematically approached these health inequities.   
 Participants in this study spanned a wide range of socioeconomic status, 
geographic location, home environment, and family structure. Despite these differences, 
the theme of socially and economically disadvantaged children having higher AD 
disease severity prevailed in the findings. Many of these disadvantaged families drove 
over an hour to see a pediatric dermatology specialist who would accept Medicaid 
patients. These families commonly lived in cluttered and overcrowded homes, had 
excessive mold present in bathrooms, and had indoor environments including heavy 
smoke or fragrances (see Figure 3). The fact that there were families within this study 
who could not afford heat in the winter or who had to funnel running water from their 
sink into their bathtub yet prioritized driving their child two hours to seek health care for 
their severe AD highlights the necessity for policy change within the American health 
care system. Possible reform actions include the creation of culturally competent health 




providing care to low income patients, and societal improvements including job creation, 
economic stability, transportation access, food access, environmental sustainability, and 
educational attainment (Rudolph et al., 2013).  
Study Limitations 
 Limitations in this study’s sampling and methodology should be addressed. First, 
patients were recruited from one academic referral center in North Carolina, thus, it is 
possible that the results may not be generalizable to the State and National levels.  
Second, a non-random convenience sample from a pediatric specialty clinic was 
recruited to participate in this study, thus selection bias may have affected the results.  
Third, despite blinding the follow up investigator, blinding among participants was not 
possible, given the nature of the intervention.  Fourth, I had no measures of compliance 
in the bleach bath group following the initial intervention.  Finally, I collected follow up 
data via telephone, thus collecting an EASI score at the close of the study was not 
possible. Despite inevitable limitations in a study of this size, these results give reason 
to further research and understand the efficacy of bleach baths and the relationship 





 This study highlights the role of environmental triggers, specifically bathroom 
hygiene, and its relationship to atopic dermatitis. Current practice guidelines for 
pediatric atopic dermatitis include the recommendation of dilute bleach baths for 
improvement in symptom management as well as reduction of skin infections. 




the epidermal Staphylococcus aureus load (Guzik et al., 2005). This study shows that 
the benefit of bleach baths may not be exclusively derived from soaking in bleach water, 
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Figure 1: Bathtub Culture Results, Fisher p = (0.9874)  
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Figure 2: Recurring Themes from Qualitative Assessment Compared to Intake 
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Figure 3: Geographic Distribution of Home Visits* 
*Note: to protect patient privacy, dots have been shifted slightly and may represent one 








Table 1: Patient Demographic Information 
 
 Bleach Group + 
Cleaning Group 
(Arm 1 & 2) 
Control (Arm 3) Total/ p values 
Average age 
(years) 
7.35 6.87 7.19 




- - Fisher p = (0.5546) 
Black 22 (55%) 7 (35%) 29 (48.3%) 
White 10 (25%) 9 (45%) 19 (31.7%) 
Asian 2 (5%) 1 (5%) 3 (5%) 
Multiracial 4 (10%) 2 (10%) 6 (10%) 
Other 1 (2.5%) 1 (5%) 2 (3.3%) 
Ethnicity (self-
reported) 
- - Fisher p = (1) 
Hispanic or Latino 1 (5%) 1 (5%) 2 (5%) 
Non-Hispanic or 
Latino 
37 (95%) 19 (95%) 56 (95%) 
Insurer - - Fisher p = (0.3026) 
Aetna 0 (0%) 1 (5%) 1 (1.7%) 
BCBS 9 (22.5%) 1 (5%) 10 (16.7%) 
Cigna 1 (2.5%) 1 (5%) 2 (3.3%) 
Medicaid 22 (55%) 11 (55%) 33 (55%) 
NC Health Choice 0 (0%) 1 (5%) 1 (1.7%) 
Tricare 3 (7.5%) 3 (15%) 6 (10%) 
UMR 1 (2.5%) 0 (0%) 1 (1.7%) 
United 3 (7.5%) 1 (5%) 4 (6.7%) 
No Insurer 
Reported 
1 (2.5%) 1 (5%) 2 (3.3%) 
 




Table 2: Patient Medical History 
 Bleach Bath 
Group & 
Bathroom 
Cleaning Group  




- - Fisher p = (1) 
No 23 (57.5%) 11 (55%) 34 (56.7%) 
Yes 16 (40%) 8 (40%) 24 (40%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
History of Hay 
Fever? 
- - Fisher p = (0.2995) 
No 8 (20%) 16 (80%) 15 (25%) 
Yes 15 (37.5%) 3 (15%) 43 (71.7%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
History of Food 
Allergies? 
- - Fisher p = (0.6236) 
No 24 (60%) 10 (50%) 34 (56.7%) 
Yes 15 (37.5%) 9 (45%) 24 (40%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
History of Skin 
Infection Requiring 
Antibiotics? 
- - Fisher p = (1) 
No 18 (45%) 17 (85%) 27 (45%) 
Yes 21 (52.5%) 2 (10%) 31 (51.7%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
Current Topical 
Antibiotic Use? 
- - Fisher p = (0.501) 
No 37 (92.5%) 17 (85%) 54 (90%) 
Yes 2 (5%) 2 (10%) 4 (6.7%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
Current Systemic 
Antibiotic Use? 
- - Fisher p = (1) 
No 35 (87.5%) 18 (90%) 53 (88.3%) 
Yes 4 (10%) 1 (5%) 5 (8.3%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 
Current AD 
Therapy? 
- - Fisher p = (0.6056) 
Class 1 Topical 
Steroid 
25 (62.5%) 14 (70%) 39 (65%) 
Systemic 
Immunomodulator 
14 (35%) 5 (25%) 19 (31.7%) 
No Data 1 (2.5%) 1 (5%) 2 (3.3%) 







Table 3: Baseline EASI Scores 
Wilcoxon p = (0.8296) 






n 16 20 18 54 
Mean 11.34 12.53 11.53 11.84 
Std 9.81 9.45 7.26 8.74 
Min 2.40 0.20 1.70 0.20 
1st Qtr 4.27 5.90 5.55 5.35 
Median 7.35 9.06 10.60 8.80 
3rd Qtr 14.9 17.92 14.12 16.52 
Max 39.6 33.60 25.8 39.6 
 




Table 4: Baseline POEM Scores at Study Enrollment 




n 39 19 58 
Mean 14.31 13 13.88 
Std 7.3 4.97 6.61 
Min 2 4 2 
1st Qtr 7.5 10 8.25 
Median 14 12 13.5 
3rd Qtr 20 15.5 18.75 
Max 29 24 29 







Table 5: Bathtub Culture Results 
Fisher p= (0.9874) 






1+ S. aureus 2 4 1 7 
1+ S. aureus, 
2+ E. coli 
1 0 0 1 
1+ S. aureus, 
4+ KEE 
0 0 1 1 
2+ MRSA 1 1 0 2 
2+ S. aureus 1 1 1 3 
1+ KEE 1 2 1 4 
3+ KEE 0 0 1 1 
4+ E. coli 0 1 0 1 
Enteric rod, 
non-E. coli 
0 0 1 1 
No S. aureus, 
no KEE, no E. 
coli 





1 2 3 6 






Table 6: POEM Difference from Office Intake to 4 Weeks Post Intervention. 
Wilcoxon p= (0.1458) 






Number (n) 18 19 17 54 
Mean 1.94 4 0.53 2.22 
Std 6.51 6.45 3.47 5.78 
Min -10 -2 -5 -10 
1st Qtr -1 1 -1 -1 
Median 0 2 0 1 
3rd Qtr 2.75 4.5 2 3 
Max 19 21 11 21 





Table 7: 4 Week Post Intervention Survey 
 Bleach Group & 
Cleaning Group 
Control Total/ p-values 
History of Skin 
Infection in the Last 
4 Weeks? 
- - Fisher p = (0.3541) 
No 36 (90%) 16 (80%) 52 (86.7%) 
Yes 1 (2.5%) 1 (5%) 2 (3.3%) 
No Data 3 (7.5%) 3 (15%) 6 (10%) 
Topical Antibiotics 
in the Last 4 
Weeks? 
- - Fisher p = (0.2361) 
No 37 (92.5%) 16 (80%) 53 (86.7%) 
Yes 5 (12.5%) 1 (5%) 1 (1.7%) 
No Data 3 (7.5%) 3 (15%) 6 (10%) 
Systemic 
Antibiotics in Last 4 
Weeks? 
- - Fisher p = (0.7105) 
No 32 (80%) 15 (75%) 47 (78.3%) 
Yes 5 (12.5%) 3 (15%) 7 (11.7%) 
No Data 3 (7.5%) 3 (15%) 6 (10%) 
Systemic Steroids 
in the Last 4 
Weeks? 
- - Fisher p = (0.4912) 
No 33 (82.5%) 14 (70%) 47 (78.3%) 
Yes 4 (10%) 3 (15%) 7 (11.7%) 
No Data 3 (7.5%) 3 (15%) 6 (10%) 
Visit to Medical 
Provider in last 4 
Weeks for Eczema 
Flair? 
- - Fisher p = (0.3289) 
No 35 (89.7%) 15 (75%) 50 (87.4%) 
Yes 2 (5.1%) 2 (10%) 4 (6.8%) 
No Data 2 (5.1%) 3 (15%) 5 (8.5%) 









Dilute bleach (sodium hypochlorite, NaOCl) baths are commonly recommended 
in clinical practice guidelines for pediatric eczema, also known as atopic dermatitis (AD) 
management (Eichenfield, 2004, Weitz et al., 2006). Bleach baths are proposed to 
suppress epidermal Staphylococcus Aureus load, which subsequently improves atopic 
dermatitis severity (Guzik et al., 2015). Although the original randomized control trials 
(RCT) of bleach baths were promising, subsequent RCTs have shown conflicting results 
(Chopra et al., 2017). Additional evidence from a Cochrane review indicates that 
reducing the load of Staphylococcus Aureus in patients with atopic dermatitis does not 
provide clinical benefit in the absence of active infection (Bath-Hextall, 2010). 
The “atopic triad” of disease includes asthma, atopic dermatitis, and allergies that 
are commonly inherited together and are a result of hypersensitivity to certain stimuli 
(Kapoor et al., 2008). The relationship between environmental interventions and 
disease severity are much better understood in conditions like asthma than for atopic 
dermatitis. Bleach baths are inexpensive, widely accessible, alternative antibiotic 
treatment that may not worsen antibiotic resistance. This systematic review will analyze 
the current literature for the efficacy of bleach baths for both symptom management and 
infection reduction for pediatric atopic dermatitis patients.  
Methods 




This review is intended to create a descriptive analysis of currently existing 
evidence regarding efficacy of bleach baths for symptom management and infection 
reduction for pediatric atopic dermatitis patients.  
Search Strategy 
I searched PubMed and Cochrane Library databases for studies. The following 
search criteria were used in both searches: (Bleach baths OR sodium hypochlorite) 
AND (pediatric OR child OR children OR adolescent) AND (atopic dermatitis OR 
eczema). 
The PubMed search yielded 30 publications, while the Cochrane search 
identified only 1 publication. I also performed hand searching and examined reference 
lists of expert opinion publications for any additional empirical studies. The last 
searches were performed on April 24, 2020.  
 
Assessing articles for inclusion/exclusion 
I first screened search results by title and abstract using eligibility established a 
priori (Table1). After exclusion of irrelevant studies based on title and abstract, full 
articles were screened for inclusion. Inclusion criteria specified studies involving 
patients aged 6 months to 18 years of age diagnosed with atopic dermatitis. Studies 
were included from any country, published online in English before January 1, 2020. 
Included study designs were randomized control trials, non-randomized trials, case 
control studies, cohort studies, retrospective and prospective studies, and cross-
sectional studies. Excluded study types were noncomparative studies, reviews, case 




empirical evidence, and editorials. The exposure of interest was use of bleach baths. 
Outcomes included skin infection rates, patient reported symptom changes (through 
tools like the patient-oriented eczema measure or POEM score, Appendix Item 1), de-
escalation of atopic dermatitis therapy, or provider determined EASI score (eczema 





Table 1: Inclusion and Exclusion Criteria 
 Include Exclude 
Populations Pediatric patients 
(6months-18 years) with 
diagnosed atopic 
dermatitis 
Children less than 6 
months of age or adults 
older than 18, those 
without diagnosis of 
atopic dermatitis 
Intervention Dilute bleach bath 
according to clinical 
practice guidelines 
(frequency and dilution 
levels) alone or in 
conjunction with topical 
corticosteroids or systemic 
immunotherapy 
Dilute bleach baths 
outside of clinical 
practice guidelines 
(frequency and dilution 
level) 
Comparisons No bleach baths +/- topical 
corticosteroids or systemic 
immunotherapy 
All other comparisons 
Outcomes Skin infection rates, POEM 
score, EASI score, de-
escalation of current 
therapy 
All other outcome 
Study Designs Randomized controlled 
trials, non-randomized 
trials, case control study, 
cohort study, retrospective 
and prospective study,  
Noncomparative studies, 
reviews, case reports, 
case series, abstracts, 
conference 
presentations, editorials, 
and expert opinions  
Setting Any country setting N/A 
Language English All other languages 
 
Assessing Quality of Eligible Studies 
I assessed each publication for risk of bias using a modified version of the 
ROBINS-I tool (2016 version), which is a widely accepted tool for evaluating risk of bias 
in estimates of the comparative effectiveness (harm or benefit) of interventions from 




2016). The risk of bias assessment was performed by one reviewer. Studies were not 
excluded based on quality issues, in order to avoid excluding relevant findings. 
However, quality of studies was considered based upon risks verses benefits, level of 
study design, comparability between groups, reporting of outcomes, and transparency 
in methodology.  
 
Data Extraction 
I performed data extraction manually and I was the sole reviewer. Data points 
that were extracted included first author, year of publication, study design, 
comparison/control arm, type of intervention, number of patients enrolled in study, age, 
gender, level of blinding, baselines severity instruments and means, severity scale used 
for inclusion and whether thresholds were provided, inclusion and exclusion criteria, 
atopic dermatitis diagnostic criteria, medication use, bathing protocol, bleach 
concentration, duration and frequency of baths, bath-aftercare, non-adherence criteria, 
length of study, severity scores, S. aureus colonization, and frequency of adverse 
events. Extracted data were examined twice to ensure completeness. Principle 
summary measures included any barriers identified in publications’ analysis of reporting 
barriers among survey and patient reported data.  
 
Results 
The search identified 28 publications. The publications underwent screening by 
title and abstract, and 16 were determined to be irrelevant for the purposes of this 




based upon criteria outlined within Table 1. The final analysis included 12 publications. 
Figure 1 describes the article flow for inclusion and exclusion in this systematic review. 













Figure 2: Critical Appraisal Table 
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APPENDIX 2: METHODS 
 
The POEM Score 
 
Outcome methodology for atopic dermatitis has been a relatively neglected and 
unstandardized area of research. Currently, there is bias toward allegedly more 
objective measurements, deemed to be more reliable, from the physician standpoint 




been problematic as it neglects symptomatic improvement and overall patient 
experience with atopic dermatitis. The Patient-Oriented Eczema Measure (POEM) is a 
validated, patient derived assessment measure for monitoring atopic dermatitis severity 
(See Appendix Item 1) (Charmin et.al 2004). The POEM score was developed after 
more than 56 objective scoring systems recording different combinations of physical 
signs were identified in published randomized controlled trials between 1994 and 2001, 
with several measures having no data on reliability or validity (Charmin et al 2004). 
Interpretation of objective measurements obtained by clinicians is difficult for 
understanding implications on patient morbidity. Recently, health care experts have 
placed more recognition of the importance of measuring disease severity and daily lived 
challenges from the patient perspective (Clayton et al.,2007).  Patient based outcome 
measures that address symptoms, including quality of life, functional ability, pain, and 
satisfaction of care have become increasingly popular for use as primary or secondary 
outcomes in clinical trials, which provide for a more holistic and relevant evaluation for 
health care interventions (Clayton et al.,2007).  
The POEM score was developed out of a study of qualitative semi-structured 
patient interviews to identify which symptoms were most important to 435 patients in 
seen at the outpatient Department of Dermatology at the Queen’s Medical Centre in 
Nottingham, England, as well as 5 surrounding local general practices (Charmin et 
al.,2004). Patients were asked open-ended questions about the aspects of their disease 
that affected them, including “What bothers you about your eczema (AD)?” and “What 
troubles you most about your eczema?” (Charmin et al., 2004). Interviews were 




children, information was obtained from both the child and parents, depending on the 
child’s age and understanding (Charmin et al., 2013). Using answers obtained from 
these qualitative interviews, the morbidity caused by each symptom was strongly 
related to how frequently each symptom was experienced.  
While investigators developed the POEM Score, nearly 200 patients completed a 
questionnaire at the interview, however questions regarding skin tightness and redness 
were completed in fewer than 75% of respondents because of difficulties in 
understanding or assessing these symptoms (Charmin et al., 2013). Redness was also 
difficult to assess for patients with Afro-Caribbean or Asian skin types (Charmin et 
al.,2004).  Due to these difficulties, redness and tightness were excluded from the final 
outcome measure. The assessment of “soreness” was also difficult to capture, with 
parents of 35 children (all less than 4 years old) felt unable to assess this symptom on 
their child’s behalf (Charmin et al.,2004). Retention of soreness as a final outcome 
measure in the POEM Score would have necessitated a separate scoring system 
excluding soreness for children younger than 4 years.  Given this challenge, this 
symptom was also excluded (Charmin et al.,2013).  The remaining 7 symptoms 
including itch, sleep disturbance, bleeding, oozing, cracking, and flaking were combined 
into a simple POEM that allowed patients to record the frequency of experiencing these 
symptoms with a maximum score of 28 (Charmin et al.,2004).  
Content validity of the POEM score was shown by the fact that measured 
domains were directly derived from patient interviews with no further symptoms 
identified among an additional 200 patients that were questioned (Charmin et al.2013).  




assessments of disease-related quality of life. Correlation showed reasonably good 
agreement between new measures and the Dermatology Quality of Life Index and 
Children’s Dermatology Life Quality Index (Clayton et al., 2007). Ideally, determination 
of criterion validity involves correlation against a “gold-standard measure”. 
Unfortunately, there was no accepted gold-standard patient-based measure of atopic 
dermatitis severity. Thus, criterion validity was measured against patient global 
assessments of disease severity, which is a 5-point scale, and overall bother related to 
atopic dermatitis, which is a 10-point scale (Clayton et al.,2004).  In comparison to these 
two scales, there was a high correlation with both assessments (n=20; r=0.81, and 
r=0.84 respectively, P<0.001) (Clayton et al.,2004).  
The POEM Score is a simple, valid, easily interpreted, and reproducible tool for 
assessing the patient experience with atopic dermatitis symptoms. This measure 
captures the fluctuation and chronic nature of atopic dermatitis. The POEM Score is 
based on patients’ views of what constitutes disease severity and quality of life rather 
than what physicians and health care providers presume to be of importance to 
patients. This tool can be completed by most patients in 1 to 2 minutes and has proven 
to be a useful tool in routine clinical practice to give a better picture of symptom 
management at home (Clayton et al.,2004).  While further studies are needed to confirm 
its usefulness in the clinical trial setting it is still a practical tool to provide 







Bleach vs Bubbles Official Protocol: 
1. Patient Enrollment [Target = 60 patients with moderate to severe Eczema] 
• Obtain consent/assent of patient and parent 
• Assign study ID number 
• Record telephone number and address for scheduling home visit 
• Record insurer, age, race/ethnicity, history of skin infections, history of atopic 
diseases (doctor diagnosed asthma, hay fever, food allergies), current antibiotic 
use (topical or oral) 
• Obtain POEM score and eczema treatment level 
• Randomize 2/3 of patients to intervention arm (bathroom cleaning) and 1/3 to 
control arm (no cleaning) using RANDBETWEEN() function in Microsoft Excel 
• [1,2] = intervention arm, [3] = control arm 
2. Schedule Home Visit 
3a. Home Visit for Intervention Arm 
• Obtain baseline photographs of bathrooms taking care to document the bathtub 
and any damage prior to cleansing 
• Obtain bacterial culture from floor and sides of bathtub 
• Clean bathrooms using provided products 
• Obtain follow up photographs of bathroom after cleaning 
• Perform qualitative interview 
• Call blinded POEM score assessor (Dr. Burkhart, Morrell, Evans, or McShane) to 
obtain baseline POEM score and link to study ID number 
• Randomize ½ of patients to bleach bath teaching arm and ½ to no further 
intervention using RANDBETWEEN() function in Microsoft Excel 
• [1] = provide bleach bath teaching, [2] = do not provide bleach bath 
teaching 
• Complete qualitative reflection 
3b. Home Visit for Control Arm 
• Obtain photographs of bathroom used by patient taking care to document the 
bathtub 
• Obtain bacterial culture from the floor and sides of bathtub 
• Call blinded POEM score assessor (Dr. Burkhart, Morrell, Evans, or McShane) to 
obtain POEM score and link to study ID number 
4. One Week Follow-Up 
• Blinded POEM score assessor (Dr. Burkhart, Morrell, Evans, or McShane) calls 
to obtain POEM score and link to study ID number 
• The same person reports culture results to family and instructions on how to 
sanitize bathroom if a pathogen is found (S. Aureus). 
5. Four Week Follow-Up 
• Blinded POEM score assessor (Dr. Burkhart, Morrell, Evans, or McShane) calls 
to obtain POEM score and link to study ID number 
• Also document current level of eczema therapy, antibiotic use in last 4 weeks 






Cleaning Steps for Home Investigator: 
BEFORE ANYTHING: 
• TAKE BEFORE PHOTO OF BATHROOM w/DISPOSABLE CAMERA**** 
• Put a grocery bag in the bucket to use as your trash bag  
 
1. TUB/SHOWER 
• sponge with disinfectant solution over tub/tile walls (basically all over) 
• fill blue bowl with H2O and rinse off 
• (other bowl) fill with ¼ baking soda + H2O and use sponge w/this over 
same areas as disinfectant and rinse  




• Baking soda + apple cider vinegar (ACV) and let sit 15 minutes 
  
**while you’re waiting on the drain to “soak” is perfect time to finish up the rest of the 
bathroom** (I usually would set a timer on my watch for the drain since it’s easy to lose 
track of time) 
 
3. TOILET 
• Paper towel + disinfectant   
• Essentially on all “external” parts of the toilet 
• Good to use paper towels for this as they are easy to throw away 
• Spray disinfectant into toilet bowl and scrub with toilet brush 
• Baking soda + water mixture and basically just “dump” it throughout the 
toilet bowl and scrub with toilet brush 
• FLUSH 
• (toilet is now done! I like putting the brush over the toilet bowl and 




• Paper towel + counter solution  
 
5. GLASS/MIRRORS 
• CLOTH rag + ACV mirror solution  
• It does NOT take much!  
• The cloth rags are key 
1. (reduce smudging vs. using something like paper towel) 
• *if there are any chrome-type material knobs, handles, etc. throughout the 
bathroom, I’ll try to use the cloth rag and mirror solution to buff them 
6. FLOORS 




• Spray floor solution everywhere, do easy scrub with Swiffer rag on Swiffer 
tool  
 
7. WRAPPING UP BATHROOM PORTION 
• Run some water down the drain and get rid of any baking soda residue 
• TAKE AFTER CLEANING PICTURE 
 
FINAL STEPS  
• Show the bathroom to the family/whoever is at the house that you spoke 
with upon arriving (typically mom and patient)  
• Run through the general steps of the cleaning process/what you 
used to explain to them what you did  
1. Hand them their copy of the cleaning supplies, recipes, and 
information on how to clean, leave it with them as a 
resource. 
• Time for FINAL INTERVIEW 
• Run through the questions at the BOTTOM of the “Step 2B Home 
Visit Qualitative Analysis” document with the parents 
1. (this is the same document where you will fill in your 
observations throughout the visit—i.e. status of the home, 
neighborhood, etc.) 
 
























Item 3: Cleaning Handout for Patient Families 
 
Bathroom	Cleaning	Recipes	 
Counters, Floors, and Walls Mix 7 drops of dish soap in a standard size 
(24 oz.) spray bottle and fill with water.  
Tubs, Tiles, Showers, Toilets Mix baking soda with warm water.  
Floors Add a half cup white vinegar to a half gallon 
water. No need to rinse. Cleans linoleum and 
tile.  
Glass Mix a half cup of white vinegar with a half 
cup water.  
Drains Pour a half cup of baking soda down the 
drain, then a half cup white vinegar. Wait 15 
minutes, then pour hot water down the drain.  
Areas of Mold growth on hard surfaces Mix 1 cup (8 ounces) of bleach with 1 gallon 
of water.  Scrub with a stiff brush and rinse 
with clean water.  Allow to air dry. 
Disinfecting areas: cleaning areas where 
someone has an infection (we will use this 
method for the bathtubs and showers) 
Mix 1 quart of water, add 1 tablespoon 
bleach.  Wipe down with a clean cloth or 
sponge.  Allow to air dry. 
 
Bathroom Cleaning Resources: 
The Centers for Disease Control and Prevention resources: 
- Household Cleaning and Sanitizing: 
https://www.cdc.gov/healthywater/emergency/cleaning-sanitizing/household-cleaning-
sanitizing.html 
- Caring for Yourself While Caring for Others.  Module 3: Tips for Reducing Risks from 
Environmental Exposures When Providing Homecare: 
https://www.cdc.gov/niosh/docs/2015-102/module3.html 
Oregon Homecare Commission.  












Item 4: Qualitative Guide for Home Investigator  
Step 2b: Home Visit Qualitative Assessment (to be typed and printed) 
Study ID#_____ 
 
Bleach versus Bubbles 
Domain 1: Environment 
1. Description of neighborhood, general appearance of home, and presence of 
pets, pests, fragrance, dust, evidence of smoking, or water damage [triggers]. 
2. Description of the bathrooms (musty smell or evidence of mold?) (OBTAIN PRE- 
AND POST-CLEANING PHOTOGRAPHS).* 
3. Description of hospitality and interactions with host family [personal contact quality 
and Nickel and Dimed]. 
4. Description of bonding and support from co-investigators [Nickel and Dimed]. 
Domain 2: Work difficulty 
1. Description of activities performed [Nickel and Dimed]. 
2. Description of any physical, mental, or emotional difficulties related to cleaning 
[Nickel and Dimed]. 
3. Suggestions for improving work experience and/or making the work more 
efficient. 
Domain 3: Assessment of service satisfaction, self-efficacy, and planning 
1. Does the family expect the bathroom cleaning and education to helpful for their 
child’s eczema [accuracy and quality]? 
2. Did the family find the bathroom cleaning met or exceeded their expectations 
[condition and quality]? Does the family feel the bathroom is in better condition after 
the cleaning [condition]? 
3. Was the family satisfied with the scheduling and timeliness of the cleaning 
[timeliness]?  
4. Does the family have recommendations to make the intervention more useful for 
eczema care? 
5. Did the family understand the cleaning sheet and plan to use any of the cleaning 
techniques we used in the future [information quality]? 
6. If provided, did it seem that the family understood and planned to follow the 
bleach bath instructions [information quality]? 
 
References and Explanation of Themes: 
Ehrenreich B. Nickel and Dimed: On (Not) Getting By in America. Henry Holt and Company 2001. 
• Used to obtain work difficulty themes (https://www.litcharts.com/lit/nickel-and-dimed/themes) 
Soh KL, Chin SH, and Wong WP. A theoretical model to investigate customer loyalty on logistics service 
providers for sustainable business performance.  Int. J. Business Performance and Supply Chain 
Modelling. 2015. 7(3):212-232. 
• Utilized for service satisfaction themes 
National Cancer Institute. Theory at a Glance: A Guide for Health Promotion Practice. 2005. NIH 
Publication No. 05-3896. 
• Utilized elements of Precaution Adoption Process Model and Social Cognitive Theory for planning 
questions 
Eichenfield et al. Current guidelines for the evaluation and management of atopic dermatitis: A 
comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology 
guidelines. J Allergy Clin Immunol 2017;139:S49-57.  










Item 5: Patient Information and Instructions on Bleach Baths 
How to Make Dilute Bleach Baths  
Baths with a small amount of bleach in them may be helpful for your child’s atopic 
dermatitis by helping to get rid of germs that cause infections. You should be careful 
when giving bleach baths. Bleach that is not watered down (diluted) is a dangerous 
household poison.  
• DO NOT use undiluted bleach directly on the skin.  
• DO NOT let dilute bleach water get in your child’s eyes or in your eyes.  
• DO NOT swallow dilute bleach water.  
• Drain any unused bleach or bleach water right after use.  
• Keep your bleach bottle out of reach of children.  
• Bleach can make your bathtub slippery, so be careful to keep your child from 
falling.  
Give your child a dilute bleach bath 2 times a week: 
1. Use unscented household liquid bleach (like Clorox). Look at the bottle to 
check the concentration of bleach. On the bottle, “bleach” might be called 
“sodium hypochlorite.” These mean the same thing. The concentration should be 
around 6 to 8.75%.  
2. Measure the amount of bleach before adding it to the bathwater.  Use a 
measuring cup or measuring spoon to add the bleach to the bath.  For a full 
bathtub of water, use a half cup of bleach.  For a half-full bathtub of water add a 
quarter cup of bleach.  For a baby or toddler bathtub, add one teaspoon of 
bleach per gallon of water. 
3. While the tub is filling, pour the bleach into the water.  DO NOT apply bleach 
directly to your child’s eczema 
4. Wait until the bath is fully drawn and bleach is poured before your child 
enters the bathtub. 
5. Soak for 10 minutes. 
6. After soaking, rinse your child’s skin very well with fresh, clean, lukewarm 
water. 
7. Pat your child’s skin dry after the bath.  Use white towels to avoid bleach 
stains. 
8. Apply your child’s eczema medications immediately after the bath.  Then 
moisturize your child’s skin.  
This information sheet on bleach baths was made using information from websites 
created by the American Academy of Dermatology and the American Academy of 
Allergy Asthma & Immunology.  You can also visit these websites to learn more about 
bleach baths. 
1. Eczema and bleath baths: Follow dermatologists’ instructions to keep children 
safe (January 8, 2014): https://www.aad.org/media/news-releases/eczema-and-
bleach-baths 











Item 6: Step 1 In-Office Encounter  
Step 1: In-office Encounter 
Study ID#_____ 
Bleach versus Bubbles 
 
Treatment category:  
EASI score: ______ 
POEM score: ______ 
1. Over the last week, on how many days has your child’s skin been itchy because of their eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
2. Over the last week, on how many nights has your child’s sleep been disturbed because of their 
eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
3. Over the last week, on how many days has your child’s skin been bleeding because of their 
eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
4. Over the last week, on how many days has your child’s skin been weeping or oozing clear fluid 
because of their eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
5. Over the last week, on how many days has your child’s skin been cracked because of their 
eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
6. Over the last week, on how many days has your child’s skin been flaking off because of their 
eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
7. Over the last week, on how many days has your child’s skin felt dry or rough because of their 
eczema?  
No days 1-2 days 3-4 days 5-6 days Every day 
 
Age: ________ months/years 
Ethnicity: Latino/Hispanic 
Race:  





















History of skin infections requiring antibiotics? Yes No 
Current topical antibiotic use? Yes No 











Current systemic antibiotic use? Yes No 
Study ID# ___________ 
 
Home Visit scheduling information: 
 
Name of Patient: _________________________________ 
 
Name of Parent(s) who will be present during home visit: ________________________________ 
 




Date and Time of Home Visit: ________________________________________________________ 
 
Investigators Attending Home Visit: ____________________________________________________ 
 
 
